Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program

NCT05368038 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.

NCT NCT05368038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05368038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
Lead sponsor
Albert Einstein College of Medicine
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 10, 2021
Completion date
August 31, 2029
Enrollment
100,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acid sphingomyelinase deficiency, cerebrotendinous xanthomatosis, ceroid lipofuscinosis, neuronal, 2, fabry disease, gaucher disease, gm1 gangliosidosis, lysosomal acid lipase deficiency, metachromatic leukodystrophy, mucopolysaccharidosis ii, mucopolysaccharidosis iii-b, mucopolysaccharidosis iv a, mucopolysaccharidosis vi, mucopolysaccharidosis vii, niemann-pick disease, type c